Oncolytic Sindbis virus targets tumors defective in the interferon response and induces significant bystander antitumor immunity in vivo.
about
Exploiting tumor epigenetics to improve oncolytic virotherapyDengue virus targets the adaptor protein MITA to subvert host innate immunityViral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-AntagonistsDengue Virus Impairs Mitochondrial Fusion by Cleaving MitofusinsThe in vivo therapeutic efficacy of the oncolytic adenovirus Delta24-RGD is mediated by tumor-specific immunityHigh efficiency of alphaviral gene transfer in combination with 5-fluorouracil in a mouse mammary tumor model.Functional analysis of the short isoform of orf virus protein OV20.0.Oncolytic virotherapy for ovarian cancer.Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancerSindbis viral vectors transiently deliver tumor-associated antigens to lymph nodes and elicit diversified antitumor CD8+ T-cell immunity.Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity.Clonal variation in interferon response determines the outcome of oncolytic virotherapy in mouse CT26 colon carcinoma model.Interferon-Mediated Tumor Resistance to Oncolytic Virotherapy.Oncolytic Alphaviruses in Cancer Immunotherapy.Interferon-β sensitivity of tumor cells correlates with poor response to VA7 virotherapy in mouse glioma models.H-Ras Exerts Opposing Effects on Type I Interferon Responses Depending on Its Activation Status.Comparative protein profiling of B16 mouse melanoma cells susceptible and non-susceptible to alphavirus infection: Effect of the tumor microenvironment.Resistance to two heterologous neurotropic oncolytic viruses, Semliki Forest virus and vaccinia virus, in experimental glioma.Systemically Administered Sindbis Virus in Combination with Immune Checkpoint Blockade Induces Curative Anti-tumor Immunity.Inhibition of Japanese encephalitis virus infection by the host zinc-finger antiviral proteinAlphaviruses in gene therapySTAT3 Cooperates With Phospholipid Scramblase 2 to Suppress Type I Interferon Response
P2860
Q21131237-61099CDF-9EC3-441C-9083-9572FF6E6998Q21558785-62E4B0CF-ED0C-49DD-8868-C68D6DA54A44Q26745547-717FAB4A-2ADC-4DC0-AAE2-1DD7CC6A31A0Q27316360-20206751-3F18-45CF-81A0-36F3156D76DCQ33670728-AFCD8616-9839-4248-96A4-DC136A633FDFQ33828697-85D69A41-121C-4770-B9A1-50A52FDE0964Q35488710-ECEA2304-47A0-4540-8917-16E52837C900Q35597082-DBBC67E3-65DA-4000-B891-0B1E7265D262Q37225501-8274195B-5F0E-47C2-B8CF-9E2D8179BD30Q37690452-BD2952C0-DF74-42BD-B9B4-3E4B0FBCAF69Q37707676-8234183A-CD1E-4B6A-A529-BD253DE53CFBQ38955561-C6EB622C-D5FA-4DE9-A436-6743BEBEE515Q39109430-77B43D39-DEDF-4B1D-8C1C-3DF6F213EDF0Q39247874-B9819F98-70A6-4072-9FBD-245C89B8797AQ39376227-A671631C-2AAA-4D2A-8B0A-9887FD1FFAEBQ40067130-B47D703D-2DE5-41B3-A589-E3C0EEC4E5D9Q40537831-A5CC2843-D6F9-4530-B758-B5607B6CC6A2Q42010342-35C376C4-FDFE-4EAA-AB9B-43A87D6AB3A1Q55516226-B7DDA034-17AF-4E02-ABE8-D4960909F986Q56000528-DA41A387-0BE6-4ECD-AC76-6F22479900B0Q56921680-6449A423-9158-4477-AA79-F5D06A4F4C61Q58777439-61FE4308-522D-4959-BEF0-1950D491DE7C
P2860
Oncolytic Sindbis virus targets tumors defective in the interferon response and induces significant bystander antitumor immunity in vivo.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Oncolytic Sindbis virus target ...... er antitumor immunity in vivo.
@ast
Oncolytic Sindbis virus target ...... er antitumor immunity in vivo.
@en
type
label
Oncolytic Sindbis virus target ...... er antitumor immunity in vivo.
@ast
Oncolytic Sindbis virus target ...... er antitumor immunity in vivo.
@en
prefLabel
Oncolytic Sindbis virus target ...... er antitumor immunity in vivo.
@ast
Oncolytic Sindbis virus target ...... er antitumor immunity in vivo.
@en
P2093
P2860
P356
P1433
P1476
Oncolytic Sindbis virus target ...... er antitumor immunity in vivo.
@en
P2093
Jih-Huong Guo
Lih-Hwa Hwang
Pong-Yu Huang
P2860
P304
P356
10.1038/MT.2011.245
P577
2011-11-08T00:00:00Z